Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Marvell Technology Group Ltd. (MRVL): Earnings Analysis Relative to Peers

Marvell Technology Group Ltd. (NASDAQ:MRVL) recently reported preliminary financial results for the quarter ended 2013-07-31. The company’s management reported a 10% increase in revenues from the previous quarter in its Q2 2014 earnings call. According to InsiderMonkey, Marvell Technology Group Ltd. (NASDAQ:MRVL) stock which has soared 78% is a small-cap pick for many hedge funds. Based on Marvell Technology Group Ltd. (NASDAQ:MRVL)’s preliminary result we analyze the company relative to its competitors in the semiconductor space; we recently published an earnings analysis of NVIDIA Corporation.

Marvell Technology Group Ltd.

Are Marvell’s returns Sustainable? Find out with our in-depth fundamental analysis.

Get Free Report

The table below shows the preliminary results along with the recent trend for revenues, net income and returns for Marvell Technology Group Ltd. (NASDAQ:MRVL)

Quarterly (USD million) 2013-07-31 2013-04-30 2013-01-31 2012-10-31 2012-07-31
Revenues 807.1 734.4 775.3 780.9 816.1
Revenue Growth % 9.9 (5.3) (0.7) (4.3) 2.5
Net Income 61.8 53.2 50.2 68.8 93.1
Net Income Growth % 16.2 6.1 (27.1) (26.1) (1.6)
Net Margin % 7.7 7.2 6.5 8.8 11.4
ROE % (Annualized) 5.7 4.8 4.4 5.8 7.7
ROA % (Annualized) 4.8 4.1 3.7 5.0 6.6

 The Market Sees Faster Growth for MRVL

While Marvell Technology Group Ltd. (NASDAQ:MRVL)’s revenues growth has been around the peer median in recent years (4.1% vs. 4.8% respectively for the past three years), the market gives its shares a higher than peer median PE ratio of 27.7. The market seems to see faster growth ahead.

Is Marvell Technology Group Under-investing?

The company’s annualized rate of change in capital of 0.5% over the past three years is less than its peer median of 13.7%. This investment has generated a peer median return on capital of 12.1% averaged over the same three years. The median return on capital investment on a relatively lower investment suggests that the company is under investing.

Earnings Quality: Possible overstatement of reported net income

Marvell Technology Group Ltd. (NASDAQ:MRVL)’s reported net income margin for the last twelve months is around the peer median (7.6% vs. peer median of 7.8%). However, the company has also recorded a relatively low level of accruals (9.0% vs. peer median of 12.2%) which suggests possible overstatement of its reported net income.

The company’s accruals over the last twelve months are positive suggesting a buildup of reserves. But this level of accruals is less than the peer median — which suggests that while Marvell Technology Group Ltd. (NASDAQ:MRVL) is building reserves, it is doing so in a relatively modest manner compared to its peers.

Quarterly Accruals Trend for Marvell Technology (NASDAQ:MRVL)Annual Accruals Trend for Marvell Technology (NASDAQ:MRVL)

Peers used for Marvell Technology earnings analysis

Intel Corporation (NASDAQ:INTC), Texas Instruments Incorporated (NASDAQ:TXN), Broadcom Corporation (NASDAQ:BRCM), Linear Technology Corporation (NASDAQ:LLTC), NVIDIA Corporation (NASDAQ:NVDA), STMicroelectronics N.V. (ADR) (NYSE:STM), LSI Corp (NASDAQ:LSI), ASM International NV (ADR) (NASDAQ:ASMI), Cypress Semiconductor Corporation (NASDAQ:CY) and PMC-Sierra Inc (NASDAQ:PMCS).

Is Marvell less cost conscious than its peers? Find out with the complete fundamental analysis!

Get Free Report


Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!